IDEAYA Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
IDEAYA Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue7.0023.3950.9327.9419.540.00
Cost of Revenue294.67129.5189.5458.1639.700.00
Gross Profit-287.67-106.1250.9327.94-20.160.00
Operating Expenses
Research & Development294.67129.5189.5458.1639.7034.32
Selling, General & Administrative39.3028.3123.9020.0515.189.95
Operating Expenses333.98157.81113.4378.2115.1844.27
Operating Income-326.98-134.43-62.50-50.27-35.34-44.27
Other Income/Expense
Interest Income52.5021.473.150.510.830.00
Interest Expense0.000.000.000.000.000.00
Other Income/Expense52.50-21.47-3.85-0.51-0.85-2.30
Income
Income Before Tax-274.48-112.96-58.66-49.76-34.50-41.98
Income Tax Expense0.000.000.000.000.000.00
Net Income-274.48-112.96-58.66-49.76-34.50-41.98
Net Income - Continuous Operations-274.48-112.96-58.66-49.760.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.00
EBITDA-323.14-130.42-58.99-47.24-33.96-41.20
EBIT-326.98-134.43-62.50-50.27-35.34-41.98
Depreciation & Amortization3.834.012.103.031.381.20
Earnings Per Share
Basic EPS-3.00-2.00-1.00-1.00-1.00-3.00
Diluted EPS-3.00-2.00-1.00-1.00-1.00-3.00
Basic Shares Outstanding81.6857.5241.4435.2524.7212.50
Diluted Shares Outstanding81.6857.5241.4435.2524.7212.50